- Home
- MP vs ZLAB Comparison
MP vs ZLAB Comparison
Compare MP & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MP
- ZLAB
- Stock Information
- Founded
- MP 2017
- ZLAB 2013
- Country
- MP United States
- ZLAB China
- Employees
- MP N/A
- ZLAB N/A
- Industry
- MP Metal Mining
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- MP Basic Materials
- ZLAB Health Care
- Exchange
- MP Nasdaq
- ZLAB Nasdaq
- Market Cap
- MP 4.0B
- ZLAB 3.5B
- IPO Year
- MP N/A
- ZLAB 2017
- Fundamental
- Price
- MP $23.86
- ZLAB $29.14
- Analyst Decision
- MP Buy
- ZLAB Buy
- Analyst Count
- MP 9
- ZLAB 4
- Target Price
- MP $23.94
- ZLAB $47.37
- AVG Volume (30 Days)
- MP 8.9M
- ZLAB 1.3M
- Earning Date
- MP 05-08-2025
- ZLAB 05-08-2025
- Dividend Yield
- MP N/A
- ZLAB N/A
- EPS Growth
- MP N/A
- ZLAB N/A
- EPS
- MP N/A
- ZLAB N/A
- Revenue
- MP $203,855,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- MP $64.26
- ZLAB $44.43
- Revenue Next Year
- MP $56.76
- ZLAB $48.68
- P/E Ratio
- MP N/A
- ZLAB N/A
- Revenue Growth
- MP N/A
- ZLAB 43.72
- 52 Week Low
- MP $10.02
- ZLAB $15.65
- 52 Week High
- MP $29.72
- ZLAB $39.77
- Technical
- Relative Strength Index (RSI)
- MP 47.10
- ZLAB 42.30
- Support Level
- MP $23.12
- ZLAB $30.96
- Resistance Level
- MP $25.74
- ZLAB $32.02
- Average True Range (ATR)
- MP 1.59
- ZLAB 1.24
- MACD
- MP -0.07
- ZLAB -0.19
- Stochastic Oscillator
- MP 45.37
- ZLAB 21.98
About MP MP Materials Corp.
MP Materials Corp is the producer of rare earth materials in the Western Hemisphere. The company owns and operates the Mountain Pass Rare Earth Mine and Processing Facility, the only rare earth mining and processing site of scale in North America.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.